STUDY QUESTION: Can we assess human prenatal cerebellar growth from the first until the third trimester of pregnancy and create growth trajectories to investigate associations with periconceptional maternal and fetal characteristics?
Introduction
The cerebellum originates from 6 weeks gestational age (GA) onwards, preceding most human brain structures and expanding rapidly during the second half of pregnancy (Chang et al., 2000; ten Donkelaar et al., 2003; Limperopoulos et al., 2005) . It is not surprising that this very early, fast and protracted course of development is particularly susceptible to prenatal disturbances caused by complex geneenvironment interactions (ten Donkelaar et al., 2003; Garel et al., 2011) . Impaired cerebellar development has been associated with several periconceptional and prenatal exposures including maternal folate status, smoking habit, alcohol consumption and environmental toxins (Handmaker et al., 2006; Roza et al., 2007; Cace et al., 2011; de Zeeuw et al., 2012; Koning et al., 2015) .
Prenatal cerebellar alterations and injury are associated with an increased risk for neurodevelopmental impairment (Courchesne et al., 2001; Limperopoulos et al., 2014; Shevelkin et al., 2014) Recently, MRI studies demonstrated the relation between a reduced cerebellar diameter and adverse neurodevelopmental outcomes, including general motor function, mental development and major neurologic disability, in the young child (Spittle et al., 2010; Park et al., 2014) .
In the clinical setting, prenatal cerebellar growth is usually evaluated during a routine or extended mid-trimester ultrasound scan by measuring the transcerebellar diameter (TCD) (International Society of Ultrasound in and Gynecology Education, 2007; Salomon et al., 2011) . Nowadays, TCD can even be measured reliably from the early first trimester onwards using three-dimensional ultrasound (3D-US). This facilitates longitudinal assessment of cerebellar size providing precise information on variations in prenatal growth trajectories from early gestation onwards (Rousian et al., 2013; Koning et al., 2015) . To provide new insights into the dynamic process of (ab)normal cerebellar growth, we conducted a prospective longitudinal 3D-US study including the first, second and third trimesters with follow-up until birth.
The primary aim of the study was to create a reference curve and growth trajectories of TCD from the first trimester up to the third trimester of pregnancy. Second, we aimed to confirm the hypothesis that derangements in prenatal cerebellar growth may be associated with one or more periconceptional, maternal and fetal characteristics such as age, parity, IVF/ICSI treatment, geographic origin, folate status, alcohol consumption, smoking habit and fetal gender.
Materials and Methods

Study design and ethical approval
This study was conducted in the setting of the Rotterdam Periconceptional Cohort (Predict study); an ongoing prospective cohort study at the Department of Obstetrics and Gynecology of the Erasmus MC, University Medical Center, Rotterdam, the Netherlands (Steegers-Theunissen et al., 2016).
The study protocol was approved by the Medical Ethical and Institutional Review Board of the Erasmus MC, University Medical Center in Rotterdam, the Netherlands (MEC 2004-227) . All participants and partners signed written informed consent at enrollment, also on behalf of their unborn child.
Study population
From November 2013 until March 2015, pregnant women who volunteered for the Predict study during the first trimester with ongoing singleton pregnancies were invited to undergo another set of 3D-US examinations. For the current study, we selected pregnancies without congenital malformations, conceived either spontaneously or through assisted reproductive techniques using oocytes from the participating mother only. Exclusion criteria were oocyte donation and all minor and major fetal congenital malformations. For this study, we excluded pregnancies without fetal 3D-US or questionnaire data due to withdrawal, termination of pregnancy or intra-uterine fetal death.
Study parameters and endpoints
Data on maternal characteristics, medical and obstetrical history, BMI and lifestyle behaviors were obtained through self-reported questionnaires upon enrollment before 12 weeks GA. A researcher verified the questionnaires and also measured standardized height and weight to calculate BMI at the study entry visit before 12 weeks GA. Educational level was categorized as low, middle or high and geographic origin was categorized as Dutch, Western and Non-western according to Statistics Netherlands (Statistics Netherlands, 2008) . Questionnaires filled out in the second and third trimesters provided follow-up information on pregnancy course and neonatal outcomes. These data were validated by obstetric medical records and by ultrasound reports of the routine anomaly scan performed between 18 and 22 weeks GA.
Estimation of GA was based on protocolled clinical methods using first trimester crown-rump length measurements before 13 weeks GA (Robinson and Fleming, 1975) . In pregnancies conceived through IVF/ICSI procedures, the GA was calculated from the date of oocyte retrieval plus 14 days. In pregnancies conceived through intra-uterine insemination, the GA was calculated using the insemination date. The GA in pregnancies conceived after the transfer of cryopreserved embryos was calculated from the day of embryo transfer plus 17 or 18 days, depending on the number of days between oocyte retrieval and cryopreservation.
Ultrasound
All participants received serial 3D-US examinations at 9, 11, 22, 26 and 32 weeks GA and were followed until delivery. All ultrasound examinations were performed by one certified sonographer (I.V.K.). All ultrasound scans were performed with the Voluson E8 system (GE Medical Systems, Zipf, Australia). During first trimester 3D-US scans a 6-12 MHz transvaginal transducer was used, during fetal ultrasounds we used a 1-7 MHz transabdominal transducer or a 6-12 MHz transvaginal transducer. All 3D volumes were stored digitally as Cartesian and 4D View volumes. First trimester measurements of the TCD were performed offline using 4D View Version 5.0 (GE Medical Systems) according to the protocol which was previously described (Rousian et al., 2013; Koning et al., 2015) . Only 3D-US volumes at 9 and 11 weeks GA of good quality without motion artifacts were used. Standardized biometric measurements of the TCD were obtained online during fetal ultrasound examinations. All first, second and third trimester measurements were repeated three times and the mean values of the three measurements were used for statistical analyses.
Statistical analysis
For data analyses, we used SPSS (SPSS release 21 for Windows, IBM, USA). All results with P-values <0.05 were considered statistically significant. Mean values and success rates of the TCD measurements were calculated per GA in weeks. To differentiate between first, second and third trimester cerebellar growth rates, we calculated the differences of two TCDs and divided these by the difference in GA in days between the ultrasound examinations following the equations below:
To assess the associations between the periconceptional maternal and fetal characteristics and cerebellar growth we performed linear mixed model analyses, taking into account the existing correlation for repeated measurements within one pregnancy. A random intercept only was used to model the within-subject correlation. Linear mixed models were estimated using the longitudinal cerebellar measurements as response and GA as predictor. Likelihood ratio tests were used to test which polynomials of GA best described the trajectory of the repeated cerebellar measurements. The quadratic polynomial model performed best; therefore, both GA and GA squared were included in the final model. After designating the best model fit, an equation was calculated representing the relationship between the repeated measurements of TCD and GA. Linear mixed models were estimated to investigate the associations between TCD, GA and the individual maternal conditions (Model 1). As covariates, we considered documented maternal conditions from our previous studies and literature including maternal age, BMI, geographic origin, moment of periconceptional initiation of folic acid supplement use, periconceptional smoking, periconceptional use of alcohol, parity and IVF/ICSI as mode of conception and fetal gender. All covariates were entered simultaneously in the fully adjusted model (Model 2).
Results
Study population
Between November 2013 and March 2015, 182 first trimester pregnancies were included. We excluded pregnancies resulting from oocyte donation (3); pregnancies complicated with fetal congenital malformations (5); pregnancies without fetal ultrasound examinations due to withdrawal (4) intra-uterine fetal death (1) or termination of pregnancy (1) and when questionnaire data were missing (2). Table I lists the general characteristics of the included study population of 166 pregnancies. In total, 652 of 762 (86%) of ultrasound scans were eligible for TCD measurements. The number of ultrasound measurements, their success rates and the mean TCD at each GA are shown in Table II . Figure 1A presents a spaghetti plot in which every line corresponds to the TCD measurements of each pregnancy. The mean growth rate of TCD increased during gestation with the highest growth rate during the third trimester (first trimester = 0.1691 mm/day, 95% CI = 0.0727-0.2655; second trimester = 0.2336 mm/day, 95% CI = 0.1731-0.2941; third trimester = 0.2702 mm/day, 95% CI = 0.2216-0.3175).
The relation between repeated TCD measurements and GA was estimated as the following equation:
2. 8248 0. 1124 GA × 0. 0004 GA 2 . This resulted in a mean TCD of 3.58 mm at 49 days GA, 5.74 mm at 56 GA and 8.04 mm at 77 days GA. The reference curve for the cerebellum between 9 and 32 weeks GA is presented in Fig. 1B. The results of the linear mixed models estimating the associations between the repeated cerebellar measurements and periconceptional maternal characteristics are shown in Table III . A significant negative association between pre-pregnancy BMI and cerebellar growth was found in the crude model (Model 1). The associations sustained in the fully adjusted model (Model 2) in which the cerebellar growth trajectories are 0.033 mm lower for every point increase in BMI. To validate the self-reported data of pre-pregnancy BMI, we repeated the analysis with standardized first trimester maternal BMI measurements. These results were comparable both in the crude (β = −0.0278, 95% CI = −0.0549; −0.0008, P = 0.044) and fully adjusted model (β = −0.0325, 95% CI = −0.0642; −0.0008, P = 0.045).
The analyses showed a trend toward a positive association between male gender and cerebellar growth. No significant associations were demonstrated between growth trajectories of the cerebellum and maternal age, parity, mode of conception, geographic origin, moment of folic acid supplement initiation, periconceptional alcohol consumption and smoking.
To (WHO, 2000) . Figure 1C shows the associations between cerebellar growth trajectories and these four categories (blue, underweight; green, normal; yellow, overweight; red, severe obesity). Cerebellar growth trajectories are lowest in the overweight group (β = −0.298, 95% CI = −0.597; 0.002, P = 0.05) and the obese group (β = −0.097, 95% CI = −0.526; 0.332, P = 0.66) and highest in the underweight group (β = 0.258, 95% CI = −0.220; 0.736, P = 0.29) all compared to the group with a normal BMI. Relative differences between the overweight group versus group with a normal BMI are 4.6%, 3.5%, 1.2%, 1.0% and 0.7% smaller TCD at 9, 11, 22, 26 and 32 weeks GA, respectively.
Discussion
We successfully created cerebellar growth trajectories using repeated TCD measurements from the first, second and third trimesters in a tertiary hospital population. Data analysis revealed that maternal BMI is negatively associated with cerebellar growth between 9 and 32 weeks GA. Interestingly, no significant associations were found between cerebellar growth and maternal age, parity, IVF/ICSI treatment, timing of initiation of folic acid supplements, periconceptional alcohol consumption and smoking. Male gender showed a trend toward a positive association with cerebellar growth. In agreement with previous literature, we demonstrated a nonlinear growth pattern ( Fig. 1A ) with cerebellar growth rates increasing with advancing GA, thus being highest in the third trimester (Rutten et al., 2009; Vatansever et al., 2013) .
Strengths and weaknesses
Our longitudinal study design enabled us to study cerebellar growth as a dynamic process during pregnancy. In contrast to a cross-sectional approach, we studied actual growth patterns as opposed to size at one time point. To draw more robust conclusions on the impact of maternal BMI, we analyzed associations between cerebellar growth and self-reported BMI as well as measured BMI. Epidemiological studies consider self-reported pre-pregnancy BMI an adequate measure, however, standardized BMI measurements are more precise and not influenced by recall bias. Our periconceptional cohort study is conducted in a tertiary hospital setting; therefore, the results may not be valid for the general population. Moreover, residual confounding inherent to the observational design cannot be excluded. The exploratory design of our study and the fact that findings are in line with previous literature and biological pathways do not refrain from considering the issue of multiple comparisons. Therefore, the results need to be interpreted with caution and replicated in other cohorts. strongly correlated to GA, small errors in pregnancy dating may be a confounder of cerebellar growth. Although a standardized clinical method was used to calculate GA, estimation of GA remains a challenge in prenatal growth studies as well as clinical practice (Jukic, 2015) . One could argue that the associations are an effect of (systematic) measurement errors due to a higher maternal BMI. However, a higher BMI most likely overestimates rather than underestimates the measurements and therefore cannot explain the observed negative associations.
Main findings
Our results add to the growing recognition that maternal obesity has an impact on neurodevelopmental health in offspring. We studied cerebellar growth in a tertiary hospital population without congenital malformations including abnormalities or hypoplasia of the cerebellum, and showed a negative association with periconceptional maternal BMI. This suggests that a higher BMI is associated with a slight decrease in cerebellar growth within the normal ranges of which the consequences for neurodevelopment in postnatal life need further investigation. Our findings agree with the reported altered white matter development in children of obese mothers (Ou et al., 2015) . Another study reported that every increase of one unit pre-pregnancy BMI was associated with a significant reduction of the intelligence coefficient in the child (Neggers et al., 2003) . Several studies demonstrate that children born to obese mothers are at higher risk for intellectual disability or cognitive deficit (Hinkle et al., 2012; Tanda et al., 2013; Huang et al., 2014) as well as impaired neurodevelopmental outcomes including attention-deficit hyperactivity disorder, autism spectrum disorders and other behavioral problems (Rodriguez et al., 2008; Van Lieshout et al., 2011; Jo et al., 2015; Li et al., 2016) . Interestingly, these particular impairments and mental health issues have also been associated with abnormal development of the cerebellum (Courchesne et al., 2001; Limperopoulos et al., 2014; Botellero et al., 2016) . The cerebellum has been recognized as a key player in a spectrum of neurodevelopmental complications as it is involved in a variety of sensorimotor tasks and cognitive, emotional and language behavior (Volpe, 2009; Schmahmann, 2010; D'Angelo and Casali, 2012; Wang et al., 2014) . Since reduced cerebellar volume was linked to less favorable neurodevelopmental outcome (Zwicker et al., 2016) , one could hypothesize that the cerebellum acts as an intermediate in the association between maternal BMI and neurodevelopmental outcome. A harmful intra-uterine environment resulting from an increasing BMI would then cause deviations in cerebellar growth which subsequently causes an increased risk for impaired neurodevelopment. Such a hypothesis is supported by accumulating evidence linking epigenetic modifications to early brain development and neurodevelopmental functioning (van Mil et al., 2014; Desplats, 2015) .
More clues on such a relationship can be found in human and mouse models of autism disorders demonstrating similar patterns of cerebellar DNA damage and methylation (Shpyleva et al., 2014) . Nevertheless, from this study we can only speculate on the relationship between reduced cerebellar growth and neurodevelopmental outcome due to increasing maternal BMI. The association between maternal BMI and decreased cerebellar growth trajectories may be attributable to BMI as a composite determinant of several mechanisms. Potential mechanisms include dietary intake, nutritional status, chronic inflammation and excessive oxidative stress (Rifas-Shiman et al., 2009; Denison et al., 2010; Mehta et al., 2014; Sen et al., 2014; Sullivan et al., 2015; van der Burg et al., 2016) . These mechanisms may act on the level of epigenetics causing derangements in DNA methylation in genes which play a crucial role in fetal, neonatal and adult health (Tenenbaum-Gavish and Hod, 2013; Soubry et al., 2015) . BMI can be a strong determinant of such epigenetic derangements (van Driel et al., 2009) . In addition, maternal obesity has been associated with gestational diabetes mellitus and one could speculate that the association between maternal BMI and growth trajectories could be partly explained by subclinical hyperglycemia. Razi et al. (2014) showed in an animal model that (uncontrolled) gestational diabetes induces neurotoxic effects on the Purkinje neurons in offspring. Although glucose monitoring guidelines were followed in the clinical care of all pregnancies, a subclinical hyperglycemia could have been missed. In addition, neurodevelopment could also be influenced by downstream effects of gestational weight gain, fetal growth alterations and the increased risk of pregnancy complications (Hinkle et al., 2012) . Whether these mechanisms act alone or as a component of a multifactorial process influencing prenatal neurodevelopment needs to be elucidated. Nevertheless, a higher maternal BMI offers an altered genetic, hormonal and biochemical environment for the fetus and its developing brain.
No other significant associations between cerebellar growth and periconceptional maternal and fetal factors were demonstrated. The lack of an association with folate status in particular is in contrast with our previous results (Koning et al., 2015) . Possibly, the impact of the moment of periconceptional folic acid initiation on the growing cerebellum attenuates over this larger growth trajectory. Fetal head growth was previously reported to be negatively associated with maternal smoking (Roza et al., 2007; Koning et al., 2016) . We speculate that the cerebellum in comparison to overall brain growth might be relatively protected when harmful exposures pose a risk for causing alterations. Since the cerebellum is also mostly unaffected in growth restricted fetuses, (Vinkesteijn et al., 2000) normal cerebellar growth seems preferential to head growth. Hence, finding a relation between BMI and cerebellum growth strengthens our case of an actual effect.
Future implications
As the proportion of obese women of reproductive-age worldwide has increased dramatically. Therefore, the potential adverse effects on prenatal brain development deserve more attention. In particular, it would be interesting to know whether minor deviations in prenatal cerebellar growth affect long-term neurodevelopmental outcome. Serial measurements of the cerebellum will be of additional value for studying the protracted process of cerebellar development. Future prospective birth cohorts with a focus on serial cerebellar growth measures and specific functional cerebellar outcome data are warranted. Preconception counseling and lifestyle interventions may encourage future mothers to attain a healthy weight prior to conceiving and thereby potentially decreasing the risk for impaired neurodevelopmental outcome in the new generation.
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